Related references
Note: Only part of the references are listed.Research agenda for frailty in older adults: Toward a better understanding of physiology and etiology: Summary from the American Geriatrics Society/National institute on aging research conference on frailty in older adults
Jeremy Walston et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2006)
An assessment of statin safety by muscle experts
PD Thompson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Functional decline in patients with and without peripheral arterial disease: Predictive value of annual changes in levels of C-reactive protein and D-dimer
MM McDermott et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2006)
Statin use and functional decline in patients with and without peripheral arterial disease
J Giri et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Frailty: Emergence and consequences in women aged 65 and older in the women's health initiative observational study
NF Woods et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes - New evidence for direct antiinflammatory effects of statins
C Arnaud et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Inflammatory markers and incident mobility limitation in the elderly
BWJH Penninx et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2004)
Effects of statins on nonlipid serum markers associated with cardiovascular disease - A systematic review
EM Balk et al.
ANNALS OF INTERNAL MEDICINE (2003)
The Women's Health Initiative Observational Study: Baseline characteristics of participants and reliability of baseline measures
RD Langer et al.
ANNALS OF EPIDEMIOLOGY (2003)
Implementation of the Women's Health Initiative Study Design
GL Anderson et al.
ANNALS OF EPIDEMIOLOGY (2003)
Outcomes ascertainment and adjudication methods in the Women's Health Initiative
JD Curb et al.
ANNALS OF EPIDEMIOLOGY (2003)
Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease
ER Mohler et al.
CIRCULATION (2003)
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvalstaltin, and pravastatin across doses (STELLAR* trial)
PH Jones et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease
S Mondillo et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease
MM McDermott et al.
CIRCULATION (2003)
Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels
L Ferrucci et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2002)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
Walking compared with vigorous exercise for the prevention of cardiovascular events in women
JE Manson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Short version of the CES-D (Burnam screen) for depression in reference to the structured psychiatric interview
A Tuunainen et al.
PSYCHIATRY RESEARCH (2001)
Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
MA Albert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
